PTN and Parkinson disease: In the dopaminergic system of the substantia nigra-striatum, PTN interacts with receptors PTPRZ and SDC3 to activate downstream signaling molecules (e.g. cadherins, cortactin, actin, and tubulin), and participates in regulating PD-related pathways [16, 32, 37, 76].